PTH-(7-84) exerts differential global gene expression compared to PTH-(1-84) in cultured human osteoclasts.

被引：0
|
作者：
Chris, M [1 ]
Langub, D [1 ]
Li, H [1 ]
Stromberg, A [1 ]
Malluche, HH [1 ]
Koszewski, NJ [1 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：686A / 686A
页数：1
相关论文
共 41 条
  • [31] Bone histology confirmation of ratio guidelines in 7 ESRD patients with no hyperparathyroid patient showing a 1-84 PTH (CAP)/7-84 PTH (CIP) ratio of <1.5
    Cantor, T
    Amerling, R
    CLINICAL CHEMISTRY, 2005, 51 : A237 - A237
  • [32] DEGRADING ACTIVITY FOR HUMAN PARATHYROID-HORMONE [PTH-(1-84)] IN RAT OSTEOBLAST-LIKE OSTEOSARCOMA CELL-LINE UMR106
    YAMAGUCHI, T
    BABA, H
    FUKASE, M
    KINOSHITA, Y
    FUJIMI, T
    FUJITA, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) : 762 - 768
  • [33] Relationship between increased bone mineral density and PTH receptor gene expression by human PTH (1-84) in OVX rats.
    Horiuchi, N
    JOURNAL OF DENTAL RESEARCH, 1999, 78 (05) : 1125 - 1125
  • [34] Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay
    Tsuchida, T
    Ishimura, E
    Hirowatari, K
    Matsumoto, N
    Imanishi, Y
    Jono, S
    Miki, T
    Inaba, M
    Nishizawa, Y
    NEPHRON CLINICAL PRACTICE, 2006, 102 (3-4): : C108 - C114
  • [35] Serum parathyroid hormone (PTH) levels obtained with an "Intact" in house monoclonal-antibody based assay that shows a 50% cross-reactivity with PTH-(7-84). Comparison with two commercial assays.
    Vieira, JG
    Nishida, SK
    Camargo, MT
    Obara, LH
    Kunii, IS
    Ohe, MN
    Hauache, OM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S335 - S335
  • [36] 慢性肾脏病5期患者血浆iPTH、(1-84)PTH、(7-84)PTH水平的特点及甲状旁腺切除术的影响
    陈慧敏
    邢昌赢
    张丽娜
    许雪强
    曾鸣
    杨光
    查小明
    俞香宝
    孙彬
    毛慧娟
    张波
    欧阳春
    袁杨刚
    张燕
    江瑶
    程晨
    尹彩霞
    王宁宁
    中华肾脏病杂志, 2017, 33 (01) : 15 - 21
  • [37] Comparison of growth in patients (pts.) with end-stage renal disease (ESRD) receiving maintenance dialysis (MD) using 1-84/7-84 PTH ratios
    Sheth, R. D.
    Goldstein, S. L.
    Cantor, T.
    BONE, 2007, 40 (06) : S78 - S79
  • [38] Absence of adynamic bone disease in African-Americans with CKD Stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio
    Fehmi, H.
    Osman, Y.
    Bhat, S.
    Nguyen, K.
    Daramola, O.
    Cantor, T.
    Monier-Faugere, M. -C.
    Yee, J.
    Malluche, H. H.
    CLINICAL NEPHROLOGY, 2009, 71 (03) : 267 - 275
  • [39] PTH(7-84) inhibits PTH(1-34)-induced production of 1,25-(OH)2D3 in primary cultured marine renal tubules
    Nakajima, K.
    Nobtomi, K.
    Takano, K.
    Sato, K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S353 - S353
  • [40] Differential expression of osteoblast and osteoclast markers by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34).
    Chiou, SS
    Avnur, Z
    Vickery, BH
    Cannon, PD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : T445 - T445
12345